Unknown NA INTERVENTIONAL NCT00710632

Screening to Predict Weight Loss in Patients With Cancer

Predicting Weight Loss in People With Cancer: Development of a Screening Tool

Sponsor: Queen's Medical Center

Conditions Cachexia Gastrointestinal Cancer Hematopoietic/Lymphoid Cancer Lung Cancer Unspecified Adult Solid Tumor, Protocol Specific

Interventions laboratory biomarker analysis management of therapy complications physiologic testing questionnaire administration

Updated 6 times since 2017 Last updated: Sep 16, 2013 Started: Sep 30, 2007 Primary completion: Aug 31, 2008

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Cachexia and Gastrointestinal Cancer, this trial is ongoing. The trial is conducted by Queen's Medical Center and has accumulated 6 data snapshots since 2007. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Unknown NA
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Unknown Status → Unknown
Nov 2022 — Jul 2024 [monthly]

Unknown Status NA
Jan 2021 — Nov 2022 [monthly]

Unknown Status NA
Jun 2018 — Jan 2021 [monthly]

Unknown Status NA

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Unknown Status NA

First recorded

Sep 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Queen's Medical Center

Data source: National Cancer Institute (NCI)

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Nottingham, United Kingdom